NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
DBV Technologies S.A. (NASDAQ: DBVT)
Class Period: February 14, 2018 - December 19, 2018
Lead Plaintiff Deadline: March 18, 2019
Join the action: https://www.zlk.com/pslra-1/dbv-technologies-s-a-loss-form?wire=3
About the lawsuit: During the class period, DBV Technologies S.A. allegedly made materially false and/or misleading statements
and/or failed to disclose that: (1) DBV Technologies' Biologics License Application ("BLA") for Viaskin Peanut failed to provide
the FDA with sufficient data on manufacturing procedures and quality controls; (2) consequently, DBV Technologies voluntarily
withdrew the BLA for Viaskin Peanut; and (3) as a result, defendants' statements about DBV Technologies' business, operations, and
prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the DBV Technologies S.A. class action contact jlevi@levikorsinsky.com.
Alkermes plc (NASDAQGS: ALKS)
Class Period: February 17, 2017 - November 1, 2018
Lead Plaintiff Deadline: February 25, 2019
Join the action: https://www.zlk.com/pslra-1/alkermes-plc-loss-form?wire=3
About the lawsuit: Alkermes plc allegedly made materially false and/or misleading statements during the class period and/or
failed to disclose that: (1) the FDA had advised Alkermes to follow a certain protocol in connection with its New Drug Application
submission for its drug ALKS 5461; (2) Alkermes had failed to follow that protocol; (3) consequently, an FDA advisory committee
voted 21 to 2 against the approval of ALKS 5461; and (4) as a result, Alkermes’ public statements were materially false and/or
misleading at all relevant times.
To learn more about the Alkermes plc class action contact jlevi@levikorsinsky.com.
Ferroglobe PLC (NASDAQ: GSM)
Class Period: August 21, 2018 - November 26, 2018
Lead Plaintiff Deadline: March 25, 2019
Join the action: https://www.zlk.com/pslra-1/ferroglobe-plc-loss-form?wire=3
About the lawsuit: Ferroglobe PLC allegedly made materially false and/or misleading statements and/or failed to disclose that:
(1) there was excess supply of the Company’s products; (2) demand for the Company’s products was declining; (3) as a result, the
pricing of the Company’s products would be materially impacted; and (4) as a result of the foregoing, Defendants’ positive
statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable
basis.
To learn more about the Ferroglobe PLC class action contact jlevi@levikorsinsky.com.
Micron Technology Inc. (NASDAQGS: MU)
Class Period: September 26, 2017 - November 19, 2018
Lead Plaintiff Deadline: March 25, 2019
Join the action: https://www.zlk.com/pslra-1/micron-technology-inc-loss-form?wire=3
About the lawsuit: Micron Technology Inc. allegedly made materially false and/or misleading statements during the class period
and/or failed to disclose that: (1) the Company engaged in anti-competitive behavior, including artificially restricting supply
growth of DRAM; (2) these anti-competitive efforts were reasonably likely to lead to regulatory scrutiny; (3) the Company’s
anti-competitive efforts artificially boosted its operating metrics; (4) as a result, the Company’s financial performance,
including revenue, was overstated; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s
business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more about the Micron Technology Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
